Printer Friendly
The Free Library
6,672,050 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Browse Biological products industry topic

Subtopics (116)

 

Articles

1-100 out of 100 article(s)
Title Author Type Date Words
CEL-SCI's L.E.A.P.S.[TM] H1N1 Flu Development Seen as Credibility Booster. Nov 6, 2009 315
Graceway Pharmaceuticals Acquires Worldwide Rights to GS 9191 from Gilead Sciences. Nov 6, 2009 376
Amarin Appoints John F. Thero as Chief Financial Officer. Nov 6, 2009 574
Inhibitex Reports Third Quarter 2009 Financial Results. Nov 6, 2009 2177
Helix BioMedix Reports Third Quarter 2009 Financial Results. Nov 6, 2009 1120
GTC Biotherapeutics Reports Third Quarter 2009 Financial Results. Financial report Nov 6, 2009 1316
Dynavax Appoints Francis R. Cano, Ph.D. to Board of Directors. Nov 5, 2009 272
StemCells, Inc. Reports Third Quarter Financial Results. Financial report Nov 5, 2009 1610
CREW Asks for Investigation into Why Wall Street Is Getting H1N1 Vaccine Ahead of Those Who Most Need It. Nov 5, 2009 509
China : Novartis buys China vaccine stake for $125 mln. Nov 5, 2009 357
Enzo Biochem Executive Says Oral Immune Regulation Platform Shows "Therapeutic Promise". Clinical report Nov 4, 2009 613
Genta Incorporated to Host Conference Call to Discuss Third Quarter 2009 Financial Results and Operational Priorities on November 16, 2009. Nov 4, 2009 818
Gilead Sciences to Present at the 18th Annual Credit Suisse Healthcare Conference on Wednesday, November 11. Conference news Nov 4, 2009 200
NuGEN Announces the Newest Member of its Applause Product Family. Nov 3, 2009 332
Acorda Therapeutics Reports Third Quarter 2009 Financial Results. Financial report Nov 3, 2009 1404
StemCells, Inc. Closes $12.5 Million Equity Financing. Nov 3, 2009 740
PicksThatMove.com Announces Investment Opinion Huntington Bancshares Inc., Goldcorp, CEL-SCI Corporation, Viking Systems, Inc., Yamana Gold Inc. Nov 3, 2009 726
Saudi FDA approves H1N1 vaccine ahead of hajj. Nov 2, 2009 373
Gilead Sciences Announces Plans for Phase IV Clinical Trial Evaluating First-Line Combination Therapy Versus Monotherapy in Pulmonary Arterial Hypertension. Nov 2, 2009 1457
Juvaris BioTherapeutics Initiates Phase 2 Study of Influenza Vaccine Adjuvant in Elderly Population. Nov 2, 2009 594
Enzo Biochem Reports on Favorable Clinical Trial of EGS21 for Treatment of Non-Alcoholic Steatohepatitis. Clinical report Nov 2, 2009 874
LFB Provides $10 Million of Funding To GTC Biotherapeutics. Nov 2, 2009 878
CRi Launches Advanced Tissue Image Analysis Software. Nov 2, 2009 436
GTC Biotherapeutics to Host Third Quarter 2009 Earnings Call on November 6, 2009 and Webcast the Merriman Investor Summit Presentation on November 10, 2009. Nov 2, 2009 416
(GEN) VACCINATION AGAINST SWINE FLU BEGINS IN TURKEY. Nov 2, 2009 144
United States : Gilead Sciences to present Viread Phase III clinical trial data. Nov 2, 2009 432
VICAL PRESENTS POSITIVE PRECLINCAL RESULTS WITH VAXFECTIN. Nov 1, 2009 487
STEMCELLS, INC. TO ADVANCE CELL-BASED TECHNOLOGIES. Nov 1, 2009 1040
Gilead Announces Long-Term Data from Two Pivotal Phase III Studies Evaluating Viread[R] For Chronic Hepatitis B. Oct 31, 2009 2675
United States : Geron hopes to restart stem-cell study in 2010. Oct 31, 2009 144
Company Profile for TechnoVax, Inc. Company overview Oct 30, 2009 198
Geron and FDA Reach Agreement on Clinical Hold. Oct 30, 2009 572
United States : Astra sets aside $520M for Seroquel case. Oct 30, 2009 436
United States : Fiscal 2009 results announced by Helix BioPharma. Financial report Oct 30, 2009 441
United States: Eurocopter Announces Deliveries, New Orders At Air Medical Conference. Conference news Oct 30, 2009 409
Swine flu vaccines delayed in US. Oct 29, 2009 299
China : Simcere Pharmaceutical Group to Acquire Additional Stake in Jiangsu Yanshen Biological Technology Stock Co., Ltd. Oct 29, 2009 246
China : Microbix to build Chinese flu vaccine plant. Oct 29, 2009 190
United States : AMT inks agreement with Progenika Biopharma for development of LPLchip. Oct 29, 2009 323
United States : CPL Biologicals to build new flu vaccine plant. Oct 29, 2009 96
Genta Announces Top-Line Results of AGENDA Phase 3 Trial of Genasense[R] in Patients with Advanced Melanoma. Oct 29, 2009 1149
Inhibitex Completes $23 Million Financing. Oct 29, 2009 391
Biopharma Capitalizes on Global Talent. Oct 29, 2009 533
Cerus Corporation Announces Third Quarter Financial Results. Financial report Oct 29, 2009 1091
Geron Corporation Reports 2009 Third Quarter Financial Results and Events. Financial report Oct 29, 2009 1121
Genta Incorporated Announces Conference Call to Review Top-Line Results of AGENDA Phase 3 Trial of Genasense[R] in Patients with Advanced Melanoma. Oct 28, 2009 645
HPV jab girls 'more cautious about sex'. Oct 28, 2009 202
Swine flu vaccines delayed in US. Oct 28, 2009 299
NCKU's Microalgal DHA Production Technology Transferred to VEDAN. Company overview Oct 28, 2009 2301
RTI Biologics Announces 2009 Third Quarter Results. Financial report Oct 28, 2009 1306
Helix BioMedix Completes Clinical Studies of SmartPeptides[TM] Products. Clinical report Oct 28, 2009 840
Novartis Champions Renewable Energy With New Vacaville Solar Array. Oct 28, 2009 645
StemCells, Inc. Announces $12.5 Million Equity Financing. Oct 28, 2009 615
A common ailment; Vaccine lag on swine flu is no surprise. Editorial Oct 27, 2009 460
Swine flu vaccines delayed in US. Oct 27, 2009 299
United States : Boehringer Ingelheim Animal Health Closes Deal to Acquire a Significant Portion of the Fort Dodge Animal Health Business From Pfizer. Oct 27, 2009 447
Telormedix Appoints Johanna Holldack as CEO. Oct 27, 2009 575
Acorda Therapeutics to Host Conference Call to Report Third Quarter 2009 Financial Results on November 3, 2009. Oct 27, 2009 412
Geron Announces Conference Call to Discuss Financial Results for the 2009 Third Quarter. Oct 27, 2009 200
Inhibitex to Host Conference Call to Report Third Quarter 2009 Financial Results on November 6, 2009. Oct 27, 2009 250
United States : European panel reviewing infections linked to Tysabri. Oct 26, 2009 273
Completion of Cel-Sci's New Facility Signals That Long Awaited Phase III Trial is Imminent. Oct 26, 2009 269
Gilead's Aztreonam for Inhalation Solution to be Reviewed by FDA Anti-Infective Drugs Advisory Committee on December 10, 2009. Oct 26, 2009 457
Medarex, Inc. Announces Expiration of Offer to Repurchase its 2.25% Convertible Senior Notes due May 15, 2011. Oct 26, 2009 134
Inhibitex Announces Data Presentation at the 60th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD). Oct 26, 2009 706
Swine flu vaccines delayed in US. Oct 26, 2009 299
India : Work begins on Rs 100-Crore Konark Knowledge Park. Oct 26, 2009 184
Macedonia : HPV and swine flu jabs procurement operations are scandalous. Oct 26, 2009 154
Swine flu vaccines delayed in US. Oct 25, 2009 299
Swine flu vaccines delayed in US. Oct 24, 2009 299
United States : Inhibitex to raise $23 million through private placement. Oct 24, 2009 444
United States : AVI BioPharma To Present Safety Update From Ongoing Systemic Trial Of AVI-4658 At 7th Annual Action Duchenne International Conference. Conference news Oct 24, 2009 350
Temptime Donates Vaccine Vial Monitors to Support WHO Distribution of H1N1 Vaccine to Developing Countries Most in Need. Oct 23, 2009 423
NCKU: Prof. Huey-Lang Yang Received the "2009 TWAS Prize in the Agricultural Sciences". Company overview Oct 23, 2009 1435
Inhibitex Announces Equity Financing of $23 Million. Oct 23, 2009 797
Swine flu vaccines delayed in US. Oct 23, 2009 299
Research and Markets: China Blood Products Industry Report 2009 Reveals - Hualan Biological Engineering Inc's Total Profit in 2008 was RMB218 Million. Report Oct 22, 2009 456
Acorda Therapeutics Announces Extension of Fampridine-SR PDUFA Goal Date to January 22, 2010. Oct 22, 2009 498
Research and Markets: A Global Recession Drives New Business Strategies and Evolving Business Models in the Biopharma Industry. Report Oct 22, 2009 443
Chief Medical Officer of BioTime's Subsidiary OncoCyte Corporation to Deliver Keynote Address at Fifth Chinese Congress on Stem Cell Therapy in Beijing, P.R. China. Oct 22, 2009 495
Research and Markets: Biopharma Quarter: Key Trends and Events of the Second Quarter of 2009. Oct 22, 2009 386
BioTime, Inc. Announces Approval For NYSE Amex Listing. Oct 22, 2009 629
Law Offices of Howard G. Smith Announces Investigation On Behalf of Shareholders of VaxGen, Inc. Oct 22, 2009 327
Swine flu vaccines delayed in US. Oct 22, 2009 299
H1N1 closes 6 schools in western Baghdad. Oct 21, 2009 127
Swine flu vaccines delayed in US. Oct 21, 2009 299
United States : SAFC announces $12-million expansion to Carlsbad facility. Oct 21, 2009 244
2010 NC Quality in Biopharma Conference to be hosted at NC State University's BTEC. Conference news Oct 21, 2009 442
Randstad Launches Diversa - A New Diverse Staffing Supplier. Oct 21, 2009 766
Levi & Korsinsky, LLP Investigates Possible Breach of Fiduciary Duty by the Board of VaxGen, Inc. - VXGN.OB. Oct 21, 2009 282
Entest BioMedical Announces Intent to Acquire Cancer Research Company Therinject LLC. Oct 21, 2009 333
CEL-SCI's L.E.A.P.S.[TM] Inventor Excited by H1N1 Treatment's Progress. Oct 20, 2009 246
Zacks Analyst Blog Highlights: Biogen Idec Inc., Facet Biotech Corporation, Trubion Pharmaceuticals, Bristol-Myers Squibb and Acorda Therapeutics. Oct 20, 2009 816
Gilead Sciences Announces Record Third Quarter 2009 Financial Results. Oct 20, 2009 2653
Swine flu vaccines delayed in US. Oct 20, 2009 299
Germany: Chemel AB and OrganoBalance GmbH Start Business Cooperation in Germany. Oct 20, 2009 435
Ireland : Amarin Announces Completion of $70 Million Private Placement. Oct 20, 2009 494
Battling swine flu: a small study revealed early clues for San Diego-based DNA vaccine company Inovio Biomedical last week. Chambers, Heather Brief article Oct 12, 2009 207
CEVA Sante Animale breaks ground on a new poultry vaccine production plant for its U.S. subsidiar. Oct 1, 2009 35
CryoLife receives Humanitarian Use Device designation for SynerGraft Processed Human Aortic Heart Valves. Oct 1, 2009 131

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles